high risk cytogenetics in multiple myeloma patients | Dr. Jens Hillengass #oncology #shorts #cancer OncBrothers: Practice-Changing Cancer Discussions 1:00 11 months ago 324 Скачать Далее
Special approaches to myeloma patients with high-risk cytogenetics VJHemOnc – Video Journal of Hematology & HemOnc 2:07 2 years ago 517 Скачать Далее
How to Treat Multiple Myeloma with Dr. Jens Hillengass OncBrothers: Practice-Changing Cancer Discussions 23:44 11 months ago 1 354 Скачать Далее
Tandem transplantation for patients with myeloma with high-risk cytogenetics VJHemOnc – Video Journal of Hematology & HemOnc 0:59 2 years ago 264 Скачать Далее
Identifying high-risk multiple myeloma patient subgroups using genetic and clinical factors VJHemOnc – Video Journal of Hematology & HemOnc 1:20 1 year ago 403 Скачать Далее
GRIFFIN: subgroup analysis of patients with multiple myeloma with high-risk cytogenetics VJHemOnc – Video Journal of Hematology & HemOnc 1:34 2 years ago 276 Скачать Далее
High-Risk Disease | High Impact Topic (HIT) Multiple Myeloma Research Foundation - MMRF 6:35 4 months ago 1 130 Скачать Далее
Optimizing Imaging in Multiple Myeloma | Jens Hillengass, MD | IMS 2023 HealthTree Foundation for Multiple Myeloma 3:35 9 months ago 128 Скачать Далее
What is HRMM (High-Risk Multiple Myeloma)? HealthTree University Myeloma 5:59 1 year ago 4 700 Скачать Далее
High-risk multiple myeloma: addressing challenges and unmet needs VJHemOnc – Video Journal of Hematology & HemOnc 1:43 9 months ago 372 Скачать Далее
Defining high-risk myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:49 2 years ago 235 Скачать Далее
The importance of genetic testing in high-risk multiple myeloma & targeted therapy VJHemOnc – Video Journal of Hematology & HemOnc 6:34 1 year ago 983 Скачать Далее
Effects of Dose Reductions of Lenalidomide in Myeloma Patients | Jens Hillengass, MD, PhD | ASH 2023 HealthTree Foundation for Multiple Myeloma 1:29 6 months ago 397 Скачать Далее
ASH23: CARTITUDE-2 Trial on Ciltacabtagene Autoleucel in Multiple Myeloma | Jens Hillengass, MD, PhD International Myeloma Foundation 6:54 5 months ago 223 Скачать Далее
SLiM CRAB criteria to define multiple myeloma Symptoms | Dr. Jens Hillengass | #OncologyBrothers OncBrothers: Practice-Changing Cancer Discussions 1:00 11 months ago 733 Скачать Далее
New Imaging Guidelines for Monoclonal Plasma Cell Disorders | Dr. Jens Hillengass Roswell Park Comprehensive Cancer Center 19:10 4 years ago 239 Скачать Далее
Hot Topics of Discussion in the Management of Multiple Myeloma Targeted Oncology 1:25 3 years ago 589 Скачать Далее
An analysis on patients with high-risk multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:06 2 years ago 740 Скачать Далее
Case 2: Double Refractory Patient with High-risk Cytogenetics HMP Education 10:37 10 years ago 130 Скачать Далее
Every Patient Counts, Every Story Matters: Dr. Jens Hillengass and Dr. Philip McCarthy Amgen 2:55 4 years ago 241 Скачать Далее